ArticleCell chemical biology2025

A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden.

Olivia N Rebeck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.